However, the role of HHIP in cancer is poorly understood, although it is well known that inactivating mutations in PTCH1 or Suppressor of fused homolog (SUFU) or activating mutations in SMO contribute to tumorigenesis through HH signaling activation [19,20]. Here, HHIP is linked to cancer.